VAV3 mediates resistance to breast cancer endocrine therapy Article (Faculty180)

cited authors

  • Aguilar, H; Urruticoechea, A; Halonen, P; Kiyotani, K; Mushiroda, T; Barril, X; Serra-Musach, J; Islam, A; Caizzi, L; Di Croce, C L; Nevedomskaya, E; Zwart, W; Bostner, J; Karlsson, E; Tenorio, G P; Fornander, T; Sgroi, D C; Garcia-Mata, R; Jansen, M P; Garcia, N; Bonifaci, N; Climent, F; Soler, M T; Rodriguez-Vida, A; Gil, M; Brunet, J; Matrat, G; Gomez-Baldo, L; Extremera, A I; Figueras, A; Balart, J; Clarke, R; Burnstein, K L; Carlson, K E; Katzenellenbogen, J A; Vizoso, M; Esteller, M; Villanueva, A; Rodriguez-Pena, A B; Bustelo, X R; Nakamura, Y; Zembutsu, H; Stal, O; Beijersbergen, R L; Pujana, M A

publication date

  • 2014

published in

start page

  • R53

volume

  • 16